We are analyzing https://link.springer.com/article/10.1007/s11033-023-09007-x.

Title:
ANRIL, H19 and TUG1: a review about critical long non-coding RNAs in cardiovascular diseases | Molecular Biology Reports
Description:
Cardiovascular diseases are the leading cause of death worldwide. They are non-transmissible diseases that affect the cardiovascular system and have different etiologies such as smoking, lipid disorders, diabetes, stress, sedentary lifestyle and genetic factors. To date, lncRNAs have been associated with increased susceptibility to the development of cardiovascular diseases such as hypertension, acute myocardial infarction, stroke, angina and heart failure. In this way, lncRNAs are becoming a very promising point for the prevention and diagnosis of cardiovascular diseases. Therefore, this review highlights the most important and recent discoveries about the mechanisms of action of the lncRNAs ANRIL, H19 and TUG1 and their clinical relevance in these pathologies. This may contribute to early detection of cardiovascular diseases in order to prevent the pathological phenotype from becoming established.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

pubmed, article, google, scholar, cas, noncoding, long, central, lncrna, rna, rnas, cell, anril, wang, zhang, mol, hypertension, cells, med, tug, cardiovascular, disease, httpsdoiorgs, promotes, expression, artery, diseases, biol, cancer, patients, pulmonary, rep, liu, coronary, myocardial, chen, proliferation, human, endothelial, sci, biochem, gao, httpsdoiorg, res, gene, zhao, int, population, research, lncrnas,

Topics {✒️}

met/h19/mir-216-3p/ebi3 signaling pathways pi3k/akt/gsk-3β signalling pathway met/h19/mir-148a-5p/p28 targeting mir-19a/socs1/p53 axis negatively regulating micror-29b-3p month download article/chapter renal fibrosis—turning challenges pi3k/akt/mtor pathways mir-423-5p/nox4 axis mir-29b/c1qtnf6 axis mir-1-3p/adam10 axis microrna-145-3p/smad4 axis microrna-374c-mediated foxc1 negatively regulating mir-34a pbx3/cyp1b1-dependent manner targeting muscle-enriched long inhibiting mtorc1/eif4ebp1 pathway coding rna cdkn2b-as1 instituto butantan escola de farmácia da silva lncrna h19 promotes hyperglycemic-induced inflammation full article pdf nf-κb pathway pulmonary arterial hypertension hypoxic pulmonary hypertension pulmonary artery cells sequestering mir-129-5p vascular endothelial cells systemic lupus erythematosus pulmonary vascular remodeling maladaptive cardiac remodelling coding rna h19 coding rna-h19 acute myocardial infarction mir-152/vegfa axis h19 gene imprinting privacy choices/manage cookies hypertension genetics past laboratório de dor coding rna anril downregulating lncrna tug1 lncrna tug1 involves dysregulated lncrna tug1 chronic kidney disease myocardial ischemic preconditioning endothelial cell messengers coronary artery disease human pancreatic islets

Schema {🗺️}

WebPage:
      mainEntity:
         headline:ANRIL, H19 and TUG1: a review about critical long non-coding RNAs in cardiovascular diseases
         description:Cardiovascular diseases are the leading cause of death worldwide. They are non-transmissible diseases that affect the cardiovascular system and have different etiologies such as smoking, lipid disorders, diabetes, stress, sedentary lifestyle and genetic factors. To date, lncRNAs have been associated with increased susceptibility to the development of cardiovascular diseases such as hypertension, acute myocardial infarction, stroke, angina and heart failure. In this way, lncRNAs are becoming a very promising point for the prevention and diagnosis of cardiovascular diseases. Therefore, this review highlights the most important and recent discoveries about the mechanisms of action of the lncRNAs ANRIL, H19 and TUG1 and their clinical relevance in these pathologies. This may contribute to early detection of cardiovascular diseases in order to prevent the pathological phenotype from becoming established.
         datePublished:2023-12-28T00:00:00Z
         dateModified:2023-12-28T00:00:00Z
         pageStart:1
         pageEnd:12
         sameAs:https://doi.org/10.1007/s11033-023-09007-x
         keywords:
            Cardiovascular diseases
            Genetic factors
            Non-coding RNA
            lncRNA ANRIL
            lncRNA H19
            lncRNA TUG1
            Animal Biochemistry
            Animal Anatomy / Morphology / Histology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig9_HTML.png
         isPartOf:
            name:Molecular Biology Reports
            issn:
               1573-4978
               0301-4851
            volumeNumber:51
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lívia da Cunha Agostini
               affiliation:
                     name:Universidade Federal de Ouro Preto
                     address:
                        name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tamires Cunha Almeida
               affiliation:
                     name:Instituto Butantan
                     address:
                        name:Escola Superior Instituto Butantan (ESIB), Laboratório de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Glenda Nicioli da Silva
               affiliation:
                     name:Universidade Federal de Ouro Preto
                     address:
                        name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
                        type:PostalAddress
                     type:Organization
                     name:Universidade Federal de Ouro Preto
                     address:
                        name:Departamento de Análises Clínicas (DEACL), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:ANRIL, H19 and TUG1: a review about critical long non-coding RNAs in cardiovascular diseases
      description:Cardiovascular diseases are the leading cause of death worldwide. They are non-transmissible diseases that affect the cardiovascular system and have different etiologies such as smoking, lipid disorders, diabetes, stress, sedentary lifestyle and genetic factors. To date, lncRNAs have been associated with increased susceptibility to the development of cardiovascular diseases such as hypertension, acute myocardial infarction, stroke, angina and heart failure. In this way, lncRNAs are becoming a very promising point for the prevention and diagnosis of cardiovascular diseases. Therefore, this review highlights the most important and recent discoveries about the mechanisms of action of the lncRNAs ANRIL, H19 and TUG1 and their clinical relevance in these pathologies. This may contribute to early detection of cardiovascular diseases in order to prevent the pathological phenotype from becoming established.
      datePublished:2023-12-28T00:00:00Z
      dateModified:2023-12-28T00:00:00Z
      pageStart:1
      pageEnd:12
      sameAs:https://doi.org/10.1007/s11033-023-09007-x
      keywords:
         Cardiovascular diseases
         Genetic factors
         Non-coding RNA
         lncRNA ANRIL
         lncRNA H19
         lncRNA TUG1
         Animal Biochemistry
         Animal Anatomy / Morphology / Histology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11033-023-09007-x/MediaObjects/11033_2023_9007_Fig9_HTML.png
      isPartOf:
         name:Molecular Biology Reports
         issn:
            1573-4978
            0301-4851
         volumeNumber:51
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lívia da Cunha Agostini
            affiliation:
                  name:Universidade Federal de Ouro Preto
                  address:
                     name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tamires Cunha Almeida
            affiliation:
                  name:Instituto Butantan
                  address:
                     name:Escola Superior Instituto Butantan (ESIB), Laboratório de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Glenda Nicioli da Silva
            affiliation:
                  name:Universidade Federal de Ouro Preto
                  address:
                     name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
                     type:PostalAddress
                  type:Organization
                  name:Universidade Federal de Ouro Preto
                  address:
                     name:Departamento de Análises Clínicas (DEACL), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular Biology Reports
      issn:
         1573-4978
         0301-4851
      volumeNumber:51
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Universidade Federal de Ouro Preto
      address:
         name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
         type:PostalAddress
      name:Instituto Butantan
      address:
         name:Escola Superior Instituto Butantan (ESIB), Laboratório de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil
         type:PostalAddress
      name:Universidade Federal de Ouro Preto
      address:
         name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
         type:PostalAddress
      name:Universidade Federal de Ouro Preto
      address:
         name:Departamento de Análises Clínicas (DEACL), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lívia da Cunha Agostini
      affiliation:
            name:Universidade Federal de Ouro Preto
            address:
               name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
               type:PostalAddress
            type:Organization
      name:Tamires Cunha Almeida
      affiliation:
            name:Instituto Butantan
            address:
               name:Escola Superior Instituto Butantan (ESIB), Laboratório de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil
               type:PostalAddress
            type:Organization
      name:Glenda Nicioli da Silva
      affiliation:
            name:Universidade Federal de Ouro Preto
            address:
               name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
               type:PostalAddress
            type:Organization
            name:Universidade Federal de Ouro Preto
            address:
               name:Departamento de Análises Clínicas (DEACL), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
      name:Escola Superior Instituto Butantan (ESIB), Laboratório de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil
      name:Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
      name:Departamento de Análises Clínicas (DEACL), Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Prêto, Brazil
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(442)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.09s.

LINK . SPRINGER . COM {}